Lon S. Smith
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Daniel D. Von Hoff (8 shared papers)Manuel M. Hidalgo (3 shared papers)John G. Kuhn (8 shared papers)John Randall Eckardt (8 shared papers)Geoffrey R. Weiss (7 shared papers)Howard A. Burris (5 shared papers)Ramesh K. Ramanathan (1 shared paper)Daniel A. Laheru (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Clinical Cancer Research (4 papers)Cancer Chemotherapy and Pharmacology (2 papers)Breast Cancer Research and Treatment (2 papers)Cancers (1 paper)
- Partner nations
- United StatesFranceBelgium
In The Last Decade
Lon S. Smith
21 papers receiving 3.1k citations
Lon S. Smith's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 2.1k
- Cancer Research 427
- Molecular Biology 1.1k
- Immunology 306
- Pulmonary and Respiratory Medicine 438
Countries citing papers authored by Lon S. Smith
This map shows the geographic impact of Lon S. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lon S. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lon S. Smith more than expected).
Fields of papers citing papers by Lon S. Smith
This network shows the impact of papers produced by Lon S. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lon S. Smith. The network helps show where Lon S. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Lon S. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine Plus nab -Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial Hit paper breakdown → | 2011 | 914 |
| 2 | Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors Hit paper breakdown → | 2015 | 672 |
| 3 | The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer Hit paper breakdown → | 2012 | 383 |
| 4 | 1996 | 321 | |
| 5 | 1993 | 269 | |
| 6 | 2003 | 174 | |
| 7 | 2000 | 78 | |
| 8 | 2014 | 73 | |
| 9 | 2013 | 69 | |
| 10 | 1999 | 61 | |
| 11 | 2018 | 52 | |
| 12 | 1994 | 42 | |
| 13 | 2001 | 38 | |
| 14 | 2008 | 31 | |
| 15 | 2004 | 26 | |
| 16 | 2005 | 20 | |
| 17 | A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies. | 1993 | 15 |
| 18 | 1995 | 14 | |
| 19 | 2014 | 6 | |
| 20 | 1998 | 5 |
About Lon S. Smith
Lon S. Smith is a scholar working on Oncology, Genetics, Neurology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Cancer therapeutics and mechanisms (3 papers), Neutropenia and Cancer Infections (2 papers), Advanced Breast Cancer Therapies (2 papers), Neuroblastoma Research and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), HER2/EGFR in Cancer Research (2 papers) and Mass Spectrometry Techniques and Applications (1 paper). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (427 citations), Molecular Biology (1.1k citations), Immunology (306 citations) and Pulmonary and Respiratory Medicine (438 citations). Lon S. Smith has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Daniel D. Von Hoff, Manuel M. Hidalgo, John G. Kuhn, John Randall Eckardt, Geoffrey R. Weiss, Howard A. Burris, Ramesh K. Ramanathan, Daniel A. Laheru, N.V. Rajeshkumar and Ronald Lee Korn. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Breast Cancer Research and Treatment and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.